Baxter International, Inc.

749 articles with Baxter International, Inc.

• Baxter Announces 5 Million Home Dialysis Treatments Managed Globally with Sharesource Remote Patient Management

  1/17/2019

  Sharesource remote patient management – now available in 40 countries – is evolving peritoneal dialysis practice management

• Baxter Starts U.S. Clinical Trial for on-Demand Peritoneal Dialysis Solution System

  1/7/2019

  First patients have been enrolled in the clinical trial for next generation dialysis technology

• Baxter Signs Open Data Pledge to Improve Patient Safety

  1/2/2019

  The Patient Safety Movement Foundation (PSMF) announced today that Baxter International Inc. (NYSE:BAX), a global medical products company, has signed the PSMF’s Open Data Pledge as the 89th company to demonstrate the importance of data sharing to improving patient safety.

• Baxter Launches Curved Applicator for Floseal, Expanding Use of Leading Hemostat During ENT Procedures

  12/18/2018

  New applicator provides surgeons with greater control during ENT surgeries to help foster improved outcomes for patients

• Baxter Appoints Patricia Morrison and Amy Wendell to Its Board

  12/6/2018

  Addition of industry veterans reflects ongoing board refreshment efforts and commitment to further diversification

• Baxter Supports New EFCNI Standards in Newborn Care in Raising Awareness of Risks from Malnutrition

  12/6/2018

  Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, is collaborating with the European Foundation for the Care of Newborn Infants (EFCNI) to raise awareness for the new EFCNI standards that address the disparities in newborn care in Europe

• Baxter to Present at the 37th Annual J.P. Morgan Healthcare Conference

  12/4/2018

  Baxter International Inc. will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 7, 2019 at 10 a.m. Pacific Time.

• Baxter Unveils New Products at the ASMBS – Obesity Week Meeting to Help Surgeons Overcome Challenges During Bariatric Surgery

  11/14/2018

  Peri-Strips Circular with Secure Grip technology provides several advantages in application and patient outcomes

• Baxter Declares Quarterly Dividend in 2019 and Announces Expanded Share Repurchase Authorization

  11/13/2018

  The indicated annual dividend rate is $0.76 per share of common stock.

• Baxter Highlights Data at ISPOR Europe 2018 on Clinical and Economic Benefits When Addressing Malnutrition, Intraoperative Bleeding

  11/13/2018

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, is presenting four health economics and outcomes research (HEOR) analyses this week at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe 2018 meeting.

• Baxter Introduces New Tisseel Prima Syringe at 2018 American Association of Gynecologic Laparoscopists Meeting

  11/12/2018

  Next-generation syringe provides physicians with enhanced speed, precision and control during surgery

• Baxter to Present at Citi’s 2018 Global Healthcare Conference

  11/6/2018

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at Citi’s 2018 Global Healthcare Conference on Thursday, December 6, 2018, in New York. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 11:45 a.m. EST.

• Baxter Reports Third-Quarter 2018 Results and Updates Financial Outlook for Full-Year 2018

  10/31/2018

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2018 and updated its full-year 2018 financial outlook.

• Baxter Highlights Clinical Data at ASN: Kidney Week Showing How New Technologies Are Advancing Dialysis Care across Modalities

  10/29/2018

  Thirteen studies presented on HDx therapy enabled by Theranova adding to significantly growing global clinical evidence

• Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies

  10/29/2018

  ​Innovative features inspired by clinician feedback make delivering therapy simpler and more efficient

• Baxter Announces U.S. Regulatory Filing for PrisMax Acute Care System and Presentation of 15 Abstracts to Start ASN: Kidney Week 2018

  10/25/2018

  PrisMax incorporates advanced technology for continuous renal replacement therapy (CRRT) designed to increase accuracy and performance for critically ill patients

• Baxter to Showcase Critical Care Innovation at the 2018 European Society of Intensive Care Medicine Congress

  10/19/2018

  Product innovations with recent approvals across Baxter’s Acute Therapies, Clinical Nutrition and Medication Delivery businesses to be featured

• Baxter and ASPEN Launch “SmartPN” Tools to Reinforce Appropriate Use of Parenteral Nutrition

  10/10/2018

  Today the American Society for Parenteral and Enteral Nutrition (ASPEN), an organization which drives the science and practice of clinical nutrition, and Baxter International Inc.

• Baxter and Mayo Clinic Announce Collaboration to Establish Renal Care Center of Excellence in the U.S.

  10/2/2018

  Collaboration combines the clinical expertise of Mayo Clinic and Baxter Renal Care Services

• Baxter Collaborates with University of Southern California Center for Body Computing to Advance Digital Health Solutions

  9/28/2018

  Focuses on digital health initiatives intended to improve health outcomes and drive increased efficiency